Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: Patricia who wrote (1823)	1/13/1999 10:45:00 AM
From: chirodoc	Read Replies (2) \| Respond to of 6039

MORE GREAT NEWS!!!!!!! Thermal Medical Imaging Expanding Number of Sites for Clinical Trials of its Proprietary Breast Imaging System PR Newswire - January 13, 1999 09:15 Company Seeks to Accelerate FDA Approval Process OGDEN, Utah, Jan. 13 /PRNewswire/ -- Thermal Medical Imaging (TMI), Inc., a subsidiary of Computerized Thermal Imaging, Inc. (OTC Bulletin Board: COII) (CTI) announced today that it plans to add several additional clinical sites to the current trials of its proprietary breast imaging system. "We are actively seeking to expand the number of centers in our clinical trials so that we can accelerate the gathering of data to be submitted to the FDA," said David A. Packer, President of TMI. Clinical trials are currently underway at Norris Cancer Hospital and Los Angeles County Hospital in Los Angeles, Mt. Sinai Medical Center in Miami Beach and Providence Hospital in Washington D.C. Packer added, "We are fortunate to have such a prestigious group of researchers and hospitals currently conducting trials on our proprietary breast imaging system. Our ability to expand this program is largely due to their hard work, and we are now in discussions with several new sites known for their women's health programs which should add significant momentum." The on-going clinical trials of the TMI Breast Imaging System are designed to test the system as an adjunctive procedure to mammogram and clinical breast exam to assist doctors in differentiating benign from malignant breast anomalies prior to biopsy. The results from pilot studies indicate that the system may be a useful adjunctive technique with the potential to decrease the rate of benign biopsies by up to 38 percent. The system employs a thermal sensing device coupled with a specially developed computer algorithm that provides quantitative diagnostic information. The technique is painless, takes less than fifteen minutes to administer and involves no compression for the patient. Computerized Thermal Imaging, Inc. develops and deploys thermal imaging and associated technologies for use in the enhancement of medical screening, diagnosis and patient management. More information about CTI can be found on the Internet at www.cti-net.com or by calling CTI Public Affairs at (801) 776-4700. Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to technical risks associated with new technology development, government regulatory approvals or continued working capital. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained from time to time in the Company's SEC filings. Copies of these filings may be obtained by contacting the Company or the SEC. SOURCE Thermal Medical Imaging, Inc. /CONTACT: Jeff Lloyd or Tom J. Ekman of Sitrick And Company, 310-788-2850, for Thermal Medical Imaging, Inc./ /Web site: cti-net.com